MiR-181b is increased in human atherosclerotic plaques and abdominal aortic aneurysms (AAA), and inhibition of miR-181b suppressed the development and progression of atherosclerosis and aneurysms through increasing expression of TIMP3, elastin, and collagen (Di Gregoli et al., 2017). The gene discussed is TIMP3; the disease is triple-A syndrome.